Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text) Commentary on Twitter NEW Research—Endoscopic sinus surgery + medical therapy > medical therapy alone in pts w/ chronic rhinosinusitis w/ nasal polyps […]
The post RCT: Endoscopic sinus surgery with medical therapy vs. medical therapy alone for chronic rhinosinusitis with nasal polyps. appeared first on Links Medicus.
Covid-19: Is it safe to reduce the self-isolation period? – The BMJ
The post Perspective | Covid-19: Is it safe to reduce the self-isolation period? appeared first on Links Medicus.
German S3 Guideline: Oxygen Therapy in the Acute Care of Adult Patients – Respiration
The post German Guideline: Oxygen therapy in the acute care of adult patients. appeared first on Links Medicus.
The COVID-19 Treatment Guidelines Panel’s Statement on Anticoagulation in Hospitalized Patients With COVID-19 – NIH COVID-19 Treatment Guidelines
The post The COVID-19 Treatment Guidelines Panel’s Statement on Anticoagulation in Hospitalized Patients With COVID-19 – in the absence of contraindications, use therapeutic-dose anticoagulation with low molecular weight heparin for hospitalized patients not in the ICU who have a D-dimer above the upper limit of normal. appeared first on Links Medicus.
The COVID-19 Treatment Guidelines Panel’s Statement on Potential Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Concomitant Medications – NIH COVID-19 Treatment Guidelines Panel Commentaries: Pfizer antiviral pills may be risky with other medications – NBC News The New COVID-19 Pill, Paxlovid, Interacts with Many Medications: Cardiac Patients Take Note – The Skeptical Cardiologist See also: […]
The post Statement on potential drug-drug interactions between Ritonavir-boosted Nirmatrelvir (Paxlovid) and concomitant medications; antiarrhythmics, oral anticoagulants, immunosuppressants, anticonvulsants, antineoplastics, and neuropsychiatric drugs are among the drugs of concern. appeared first on Links Medicus.
#315 Long COVID with Dr. Monica Verduzco-Gutierrez – The Curbsiders
The post Podcast: Long COVID Pearls. appeared first on Links Medicus.
The COVID-19 Treatment Guidelines Panel’s Statement on Therapies for High-Risk, Nonhospitalized Patients With Mild to Moderate COVID-19 – NIH COVID-19 Treatment Guidelines See also: What’s New in the Guidelines – NIH COVID-19 Treatment Guidelines
The post Statement on therapies for high-risk, nonhospitalized patients with mild to moderate Covid-19. appeared first on Links Medicus.
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 – Covid Advisory for Ontario Commentary on Twitter Fantastic outpatient treatment approach from Ontario #COVID19 Clinical Practice GuidelinesRisk level:high mod lowEg:high:Sotrovimab is recommended if NA Remdesivir if NA Fluvoxamine or BudesonidePaxlovid/Molnupiravir not added coz not yet approved CA https://t.co/dDhj6vA0uv pic.twitter.com/4ucrKIcMn8 — […]
The post Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19. appeared first on Links Medicus.
Omicron’s feeble attack on the lungs could make it less dangerous – Nature
The post Omicron’s feeble attack on the lungs could make it less dangerous. appeared first on Links Medicus.
Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery – New England Journal of Medicine Commentary on Twitter In @NEJM today, @TerezaKasaeva @doctorsoumya and I write about Covid-19’s devastating impact on tuberculosis care & offer suggestions for recoveryhttps://t.co/buOEOPVWwM pic.twitter.com/BfOK3X3MuU — Madhu Pai, MD, PhD (@paimadhu) January 5, 2022
The post Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery. appeared first on Links Medicus.